Target intelligence / Profile preview

Messenger RNA 3' untranslated regions (3'UTR) (3'UTR)

Target
3'UTR
Molecular classification
Nucleic acid, Regulatory RNA element, Non-coding RNA region
01

Overview

The 3' untranslated region (3'UTR) is the section of messenger RNA (mRNA) that immediately follows the translation termination codon and extends to the poly-A tail. These regions serve as critical regulatory platforms containing binding sites for microRNAs (miRNAs) and RNA-binding proteins (RBPs), which control the stability, localization, and translation efficiency of the transcript (Mayr, 2019; Barrett et al., 2012). By modulating these interactions, the cell can rapidly adjust protein levels in response to physiological cues without the need for new transcription. In many pathological states, such as cancer, fibrosis, and neurological disorders, mutations or dysregulation within 3'UTRs can lead to the aberrant expression of oncogenes or the silencing of tumor suppressors (Conne et al., 2000; Siawrys et al., 2014). Therapeutically, targeting multiple mRNA 3'UTRs is a strategy often employed by microRNA-based drugs, where a single miRNA mimic or inhibitor can coordinately regulate an entire network of genes involved in a disease pathway (Rupaimoole & Slack, 2017). For example, miRNA mimics can restore the repressive function of a downregulated miRNA across its various target 3'UTRs to treat conditions like fibrosis or cancer. However, this multi-target approach necessitates careful design to minimize off-target effects and manage the potential for innate immune activation triggered by exogenous RNA molecules (Setten et al., 2019).

Other names
3'-untranslated region3'-UTRmRNA 3'-terminal non-coding region3'-trailer sequence
02

Mechanism of action

MicroRNA mimicry, microRNA antagonism, RNA interference (RNAi), and steric hindrance of RNA-binding protein or microRNA binding sites.

03

Biological functions

Post-transcriptional regulation of gene expressionmRNA stability and degradationTranslation initiation and repressionmRNA subcellular localizationAlternative polyadenylation
04

Disease associations

CancerFibrosisNeurodegenerative diseaseCardiovascular diseaseRare genetic disorders
05

Safety considerations

Off-target hybridizationInnate immune activationHepatotoxicityNephrotoxicityDelivery vehicle toxicity
06

Interacting drugs

Remlarsen (MRG-201)

3 more in the full profile.

07

Biomarkers

Target mRNA expression levelsDownstream protein expressionCirculating microRNA levels

Beyond the preview

Go deeper on Messenger RNA 3' untranslated regions (3'UTR) (3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Messenger RNA 3' untranslated regions (3'UTR) (3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call